INS and metabolic dysfunction-associated steatotic liver disease: In addition, losing weight decreases the hepatic TG content by decreasing de novo lipogenesis in patients with non-alcoholic fatty liver disease (NAFLD) and increasing circulating glucose and insulin [33].